Skip to main content
U.S. flag

An official website of the United States government

This site is currently in beta, and your feedback is helping shape its ongoing development.

Emtricitabine and tenofovir disoproxil fumarate

Published by U.S. Food and Drug Administration | U.S. Department of Health & Human Services | Metadata Last Checked: February 18, 2026 | Last Modified: 2025-03-17
Emtricitabine and Tenofovir Disoproxil Fumarate is a generic prescription tablet combining two antiviral medications to treat HIV infection by blocking the virus from multiplying in the body. Each tablet contains 200 mg of emtricitabine and 300 mg of tenofovir disoproxil fumarate, taken orally once daily. Manufactured by Aurobindo Pharma Limited, it's approved as an ANDA drug. This information was generated using AI and is provided for informational and research purposes only.

Find Related Datasets

Click any tag below to search for similar datasets

data.gov

An official website of the GSA's Technology Transformation Services

Looking for U.S. government information and services?
Visit USA.gov